Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0896
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-26T06:06:18.374815Z
status: published
lens: trace
sector: health
headline: Diagnosing melioidosis and tracking treatment outcomes using breath
dek: Melioidosis is a life-threatening infectious disease caused by Burkholderia pseudomallei ( Bp ). Rapid diagnosis and appropriate antimicrobial treatment are critical to reduce mortality, yet diagnosis is hindered by diverse clinical manifestations, mimicry with other diseases, and reliance on slow culture-based methods. Detecting volatile compounds offers a non-invasive approach for rapid infection detection. In this study, we aim to identify volatile compounds in patients' breath that can aid in diagnosing meli…
gain_title: Machine learning analysis of breath volatiles identified candidate markers that discriminated culture-confirmed melioidosis from other febrile illnesses with perfect AUC in a small test set and tracked culture status and treatment time during antibiotics.
problem_title: In extended testing, the three-marker panel misclassified one febrile control, and the overall pilot size limits generalizability for rapid diagnosis.
trace_subject: breath volatile markers for diagnosing melioidosis and indicating treatment response
gain_reading: Machine learning analysis of breath volatiles identified candidate markers that discriminated culture-confirmed melioidosis from other febrile illnesses with perfect AUC in a small test set and tracked culture status and treatment time during antibiotics.
gain_evidence: three breath markers-camphene, 1-butanol, and 3-methylheptyl acetate-that discriminated melioidosis ( n = 7) from febrile controls ( n = 6) with an area under the receiver operating characteristic curve of 1.00
problem_reading: In extended testing, the three-marker panel misclassified one febrile control, and the overall pilot size limits generalizability for rapid diagnosis.
problem_evidence: with one febrile control misclassified.
quick_read: By the publication date of 2026-08-25, a pilot study had collected breath samples from 17 melioidosis patients and 8 febrile controls and used two-dimensional gas chromatography mass spectrometry combined with machine learning feature selection to identify volatile signatures of infection and treatment course.

The work matters because melioidosis diagnosis currently relies on slow culture-based methods despite high mortality, so a non-invasive breath test could accelerate appropriate antimicrobials; uncertainty remains due to very small cohorts, single misclassification, and need for larger validation of the 3-marker, 4-marker, 16-compound CRP-correlated, and 144-compound time-associated panels.
limitation: Pilot design with very small discovery cohorts (n=7 vs n=6 for initial discrimination) and total n=25, so findings are candidate markers requiring larger validation before clinical use.
tag: Dual reading
key_points: Study enrolled 17 patients with culture-confirmed melioidosis and 8 patients with other febrile illnesses, with longitudinal sampling from 5 melioidosis patients over approximately one month of antibiotic treatment. | Analysis used comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry with statistical comparison and machine learning-based feature selection. | Four breath markers, three of which were hydrocarbons, differentiated samples associated with a positive Bp culture from those with a negative Bp culture. | 16 volatile compounds significantly correlated (correlation coefficient > 0.6) with blood C-reactive protein levels.
rundown: Researchers collected breath from 17 culture-confirmed melioidosis cases and 8 febrile controls, plus longitudinal samples from 5 melioidosis patients during about one month of antibiotics, and analyzed them with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.

A three-compound panel of camphene, 1-butanol, and 3-methylheptyl acetate achieved AUC 1.00 in the initial 7 vs 6 comparison and correctly classified 11 additional melioidosis samples, while a separate four-marker random forest model distinguished Bp culture-positive from culture-negative samples with 98% sensitivity and 95% specificity.
sources:
- peer_reviewed | Journal of Breath Research | https://doi.org/10.1088/1752-7163/ae4bfd | 2026-08-25
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

8c432829cbf8c0c19f7c06f68caa4ca0bac4e85527ab0a24d26bb96b3e9e7b6b

previous

0000000000000000000000000000000000000000000000000000000000000000